Billiontoone, Inc. (NASDAQ:BLLN – Get Free Report) fell 5.6% during trading on Monday . The stock traded as low as $124.01 and last traded at $122.9510. Approximately 146,159 shares were traded during trading, a decline of 70% from the average session volume of 492,120 shares. The stock had previously closed at $130.31.
Wall Street Analysts Forecast Growth
Several analysts recently commented on BLLN shares. Weiss Ratings upgraded shares of Billiontoone from a “sell (d)” rating to a “sell (d+)” rating in a research note on Tuesday, June 23rd. Guggenheim started coverage on shares of Billiontoone in a research report on Monday, June 29th. They set a “buy” rating and a $125.00 price target for the company. BTIG Research decreased their price target on Billiontoone from $140.00 to $130.00 and set a “buy” rating on the stock in a research note on Thursday, May 7th. Finally, JPMorgan Chase & Co. upped their price target on Billiontoone from $120.00 to $125.00 and gave the stock an “overweight” rating in a report on Thursday, May 7th. Six investment analysts have rated the stock with a Buy rating, three have issued a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, Billiontoone currently has a consensus rating of “Moderate Buy” and an average price target of $126.00.
Check Out Our Latest Stock Report on BLLN
Billiontoone Trading Down 3.0%
Billiontoone (NASDAQ:BLLN – Get Free Report) last released its earnings results on Wednesday, May 6th. The company reported $0.34 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.01 by $0.33. The company had revenue of $108.39 million during the quarter, compared to analyst estimates of $95.81 million. During the same period in the prior year, the business posted ($0.39) earnings per share. Billiontoone’s revenue was up 83.8% on a year-over-year basis. Equities analysts expect that Billiontoone, Inc. will post 0.93 earnings per share for the current year.
Insider Transactions at Billiontoone
In other news, insider Shan Riku Sakakibara sold 8,000 shares of Billiontoone stock in a transaction dated Wednesday, June 24th. The stock was sold at an average price of $110.00, for a total value of $880,000.00. Following the transaction, the insider directly owned 208,000 shares of the company’s stock, valued at $22,880,000. The trade was a 3.70% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Nancy Joann Johnson sold 10,582 shares of the business’s stock in a transaction dated Tuesday, June 9th. The stock was sold at an average price of $100.47, for a total value of $1,063,173.54. Following the sale, the insider owned 21,900 shares of the company’s stock, valued at $2,200,293. The trade was a 32.58% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last 90 days, insiders have sold 153,049 shares of company stock valued at $16,768,021.
Hedge Funds Weigh In On Billiontoone
Hedge funds and other institutional investors have recently made changes to their positions in the business. Baillie Gifford & Co. acquired a new stake in Billiontoone in the 4th quarter valued at $103,786,000. Emerald Mutual Fund Advisers Trust boosted its position in shares of Billiontoone by 11.9% in the first quarter. Emerald Mutual Fund Advisers Trust now owns 132,206 shares of the company’s stock worth $10,436,000 after buying an additional 14,072 shares during the period. Massachusetts Financial Services Co. MA acquired a new stake in shares of Billiontoone in the fourth quarter valued at about $13,373,000. Universal Beteiligungs und Servicegesellschaft mbH purchased a new stake in shares of Billiontoone during the 4th quarter valued at about $1,348,000. Finally, Emerald Advisers LLC lifted its position in Billiontoone by 26.8% during the 1st quarter. Emerald Advisers LLC now owns 239,562 shares of the company’s stock worth $18,911,000 after acquiring an additional 50,613 shares in the last quarter.
Billiontoone Company Profile
BillionToOne (NASDAQ: BLLN) is a molecular diagnostics company that develops and commercializes high-precision genetic testing solutions based on single-molecule counting technology. The company’s platform is designed to detect and quantify rare genetic variants and chromosomal abnormalities from cell-free DNA, with a primary focus on applications in prenatal screening and other clinical genetic tests where sensitivity and specificity at very low allele fractions are critical.
BillionToOne’s offerings center on assay development and clinical testing workflows that enable non-invasive prenatal testing (NIPT) and targeted molecular diagnostics.
Further Reading
- Five stocks we like better than Billiontoone
- A $1T Black Hole: SpaceX Eyes Pentagon AI to Break Free
- Why Gold Miners Could Be the Market’s Biggest Comeback Story
- Amazon’s AI Spending Is About to Face Its Most Important AWS Test Yet
- AI Data Centers Need Power, and These 2 Industrials Are Cashing In
Receive News & Ratings for Billiontoone Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Billiontoone and related companies with MarketBeat.com's FREE daily email newsletter.
